S 4327 · 119th CongressIn Committeecongress.gov ↗
What this bill does
AI plain-language summaryThis bill appears to require the government to review and examine pharmaceutical products that come from Chinese companies or organizations. No official summary is available for this bill.
Introduced
April 16, 2026
Policy Area
Foreign Trade and International Finance
Your Vote
Discussion (0)
Explain what is at stake in this bill.
Sign in to join the discussion.
No comments yet. Be the first.